Telix Completes Acquisition of Atlab for Prostate Cancer Program

Go back to Telix Completes Acquisition of Atlab for Prostate Cancer Program
TRANS-LUX CORPORATION (NASDAQ: TLX) Delayed: 11.97 -0.03 (0.25%)
Previous Close $12.00    52 Week High $2.18 
Open $12.14    52 Week Low $0.30 
Day High $12.15    P/E N/A 
Day Low $11.96    EPS $-3.32 
Volume 76,437